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background:  Regional intracoronary administration of cardiosphere-derived cells (icCDCs) to healed infarcts reduces infarct volume but 
does not improve left ventricular ejection fraction (LVEF). We tested the hypothesis that this reflects the failure to prevent remote zone 
remodeling and determined whether this could be overcome by global administration of CDCs immediately after reperfusion.
methods:  Using blinded methodology, immunosuppressed swine (cyclosporine 100mg/day, n=15) underwent a 60 minute LAD occlusion. 
After 30 minutes of reperfusion, they were randomized to receive vehicle or 20 x 106 allogeneic CDCs infused into the 3 major coronary 
arteries at 106 cells/min under continuous flow. Infarct volume and LV function were assessed with serial contrast MDCT.
results:  Two days after MI, LVEF and regional LV function were similarly reduced in both groups. One month later, LVEF increased 
in CDC-treated but not vehicle-treated animals (Table). This reflected improved segmental function in the infarct as well as remote 
myocardium. Functional improvement was independent of infarct volume, which declined by a similar extent in each group (Vehicle: 2.5 ± 
0.7 g vs. CDCs: 2.4 ± 1.5 g).
Conclusion:  Global delivery of icCDCs immediately after reperfusion improves LV function throughout the heart without affecting infarct 
size. Strategies to prevent remote zone myocyte loss following an infarct may more effectively ameliorate adverse ventricular remodeling 
and improve global systolic function.
 
